Deciphera Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 3, 2021
July 27 2021 - 7:00AM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced
that it will report its second quarter 2021 financial results on
Tuesday, August 3, 2021.
In connection with the earnings release, Deciphera’s management
team will host a live conference call and webcast at 4:30 PM ET on
Tuesday, August 3, 2021, to discuss the Company’s financial results
and provide a corporate update.
The conference call may be accessed by dialing (866) 930-5479
(domestic) or (409) 216-0603 (international) and referring to
conference ID 9943767. A webcast of the conference call will be
available in the “Events and Presentations” page in the “Investors”
section of the Company’s website at
https://investors.deciphera.com/events-presentations. The archived
webcast will be available on the Company's website approximately
two hours after the conference call and will be available for 30
days following the call.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
FDA-approved switch-control kinase inhibitor for the treatment of
fourth-line gastrointestinal stromal tumors. For more information,
visit https://www.deciphera.com/ or follow us on LinkedIn and
Twitter (@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210727005370/en/
Investor Relations: Jen Robinson Deciphera Pharmaceuticals, Inc
jrobinson@deciphera.com 781-906-1112
Media: David Rosen Argot Partners David.Rosen@argotpartners.com
212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Sep 2023 to Sep 2024